SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-272122
Filing Date
2020-10-19
Accepted
2020-10-19 17:05:02
Documents
14
Period of Report
2020-10-13
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d54871d8k.htm   iXBRL 8-K 45677
2 EX-3.1 d54871dex31.htm EX-3.1 6352
3 EX-3.2 d54871dex32.htm EX-3.2 57473
  Complete submission text file 0001193125-20-272122.txt   258230

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aimt-20201013.xsd EX-101.SCH 3068
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20201013_lab.xml EX-101.LAB 18891
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20201013_pre.xml EX-101.PRE 11859
7 EXTRACTED XBRL INSTANCE DOCUMENT d54871d8k_htm.xml XML 3566
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 201246723
SIC: 2834 Pharmaceutical Preparations